Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy

Abstract Metachromatic leukodystrophy (MLD) and globoid cell leukodystrophy (GLD or Krabbe disease) are severe neurodegenerative lysosomal storage diseases (LSD) caused by arylsulfatase A (ARSA) and galactosylceramidase (GALC) deficiency, respectively. Our previous studies established lentiviral gen...

Full description

Bibliographic Details
Published in:	EMBO Molecular Medicine
Main Authors:	Vasco Meneghini, Annalisa Lattanzi, Luigi Tiradani, Gabriele Bravo, Francesco Morena, Francesca Sanvito, Andrea Calabria, John Bringas, Jeanne M Fisher‐Perkins, Jason P Dufour, Kate C Baker, Claudio Doglioni, Eugenio Montini, Bruce A Bunnell, Krystof Bankiewicz, Sabata Martino, Luigi Naldini, Angela Gritti
Format:	Article
Language:	English
Published:	Springer Nature 2016-03-01
Subjects:	brain gene therapy lentiviral vectors leukodystrophy non‐human primates
Online Access:	https://doi.org/10.15252/emmm.201505850

Similar Items

Effective gene therapy for metachromatic leukodystrophy achieved with minimal lentiviral genomic integrations
by: Lucas Tricoli, et al.
Published: (2025-03-01)

Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
by: Giovanna Giacca, et al.
Published: (2024-01-01)

Family Attitudes regarding Newborn Screening for Krabbe Disease: Results from a Survey of Leukodystrophy Registries
by: Karlita Blackwell, et al.
Published: (2020-08-01)

Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials
by: Jasna Metovic, et al.
Published: (2024-07-01)

Globoid Cell Leukodystrophy (Krabbe Disease): An Update
by: Maghazachi AA
Published: (2023-10-01)

Design and Potential of Non-Integrating Lentiviral Vectors
by: Aaron Shaw, et al.
Published: (2014-01-01)

Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing
by: Soledad Banos-Mateos, et al.
Published: (2024-07-01)

Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
by: Michela Milani, et al.
Published: (2017-08-01)

Gene and Cellular Therapies for Leukodystrophies
by: Fatima Aerts-Kaya, et al.
Published: (2023-10-01)

The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
by: Luis Apolonia
Published: (2020-09-01)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

Matched Unrelated Hematopoietic Stem Cell Transplant in Juvenile-Onset Krabbe's Disease
by: Ruchira Misra, et al.
Published: (2022-01-01)

Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
by: Dietrich Matern, et al.
Published: (2024-01-01)

The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping
by: Bat-Erdene Jargalsaikhan, et al.
Published: (2025-07-01)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
by: Alexis Duvergé, et al.
Published: (2020-11-01)

Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
by: Francesco Piras, et al.
Published: (2017-06-01)

GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
by: Michela Milani, et al.
Published: (2024-04-01)

Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
by: Luigi Naldini
Published: (2019-01-01)

Lentiviral-based approach for the validation of cancer therapeutic targets in vivo
by: Chiara Ambrogio, et al.
Published: (2014-10-01)

HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease
by: Sandra O. Braz, et al.
Published: (2023-07-01)

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease
by: Jacob Favret, et al.
Published: (2024-12-01)

Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
by: Audrey Page, et al.
Published: (2020-12-01)

Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
by: Eduardo Martínez-Molina, et al.
Published: (2020-11-01)

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
by: Wendy Dong, et al.
Published: (2021-07-01)

Late‐Onset Krabbe Disease: Case Report of Two Patients in a Chinese Family and Literature Review
by: Yujun Sun, et al.
Published: (2025-02-01)

Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors
by: Ane Arrasate, et al.
Published: (2024-10-01)

Gene Therapy Applications of Non-Human Lentiviral Vectors
by: Altar M. Munis
Published: (2020-09-01)

Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production
by: Claude Bagnis, et al.
Published: (2014-06-01)

First hematopoietic stem cell transplantation in a child with late infantile Krabbe disease in Poland
by: Izabella Miśkiewicz-Migoń, et al.
Published: (2021-03-01)

Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
by: Ciara Shortiss, et al.
Published: (2021-08-01)

Outcome of two siblings with late-onset Krabbe disease following allogeneic hematopoietic stem cell transplantation: And review of literature
by: Montaha Almudhry, et al.
Published: (2025-09-01)

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer
by: Nicole Cordes, et al.
Published: (2022-09-01)

Emetine in Combination with Chloroquine Induces Oncolytic Potential of HIV-1-Based Lentiviral Particles
by: Pavel Spirin, et al.
Published: (2022-09-01)

Leucodystrophies at children
by: Wiktoria Sielwanowska, et al.
Published: (2023-08-01)

Long-term stability of clinical-grade lentiviral vectors for cell therapy
by: Julie K. Jadlowsky, et al.
Published: (2024-03-01)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
by: Balázs Bender, et al.
Published: (2013-09-01)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
by: Longfei Deng, et al.
Published: (2023-09-01)

Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
by: Narmatha Gurumoorthy, et al.
Published: (2022-01-01)

Identification of a small molecule for enhancing lentiviral transduction of T cells
by: Paulina Malach, et al.
Published: (2023-12-01)

Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD
by: Sharifah Iqball, et al.
Published: (2023-09-01)